Cointime

Amylyx Pharmaceuticals

company

About

Amylyx Pharmaceuticals specializes in providing solutions for Alzheimer’s and other diseases of the brain.

  • 101 - 250

Highlights

Total Funding Amount
$135M
Funding Rounds
1
Investors
1

Details

Last Funding Type
Series C
Last Funding Money Raised
$135M
Industries
Biotechnology,Medical,Neuroscience,Pharmaceutical
Founded date
Jan 1, 2014
Number Of Employee
101 - 250
Operating Status
Active

Amylyx Pharmaceuticals specializes in providing solutions for Alzheimer’s and other diseases of the brain. The company features a drug designed to prevent nerve cell death and degeneration.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$135M
Amylyx Pharmaceuticals has raised a total of $135M in funding over 2 rounds. Their latest funding was raised on Jul 20, 2021 from a Series C round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jul 20, 2021 Series C $135M 1 — — Detail

Investors

Number of Lead Investors
Number of Investors
—
1
Amylyx Pharmaceuticals is funded by 1 investors. Polaris Founders Capital are the most recent investors.
Investor Name Lead Investor Funding Round
Polaris Founders Capital — Series C
Cointime
เนื้อหา
บริษัท